Oncolytic viruses (OVs) harness the hallmarks of tumor cells and cancer-related immune
responses for the lysis of malignant cells, modulation of the tumor microenvironment, and …

The advantage of oncolytic viruses (OV) in cancer therapy is their dual effect of directly
killing tumours while prompting anti-tumour immune response. Oncolytic parapoxvirus ovis …

Newcastle disease (ND) has been a consistent risk factor to the poultry industry worldwide.
Its pathogen, Newcastle disease virus (NDV), is also a promising antitumor treatment …

Immunotherapies using immune checkpoint inhibitors (ICIs) and chimeric antigen receptor
(CAR) T-cell therapy have achieved successful results against several types of human …

Oncolytic virus (OV) is a new therapeutic strategy for cancer treatment. OVs can selectively
infect and destroy cancer cells, and therefore act as an in situ cancer vaccine by releasing …

Simple Summary Cervical cancer is one of the most common cancers with a high mortality
rate, especially in women of reproductive age. A lot of treatment modalities are being used in …

Oncolytic virus (OV) therapy has been shown to be an effective targeted cancer therapy
treatment in recent years, providing an avenue of treatment that poses no damage to …

Cervical cancer represents one of the most important malignancies among women
worldwide. Current therapeutic approaches for cervical cancer are reported not only to be …

Background In recent years, oncolytic viruses (OVs) have drawn attention as a novel therapy
to various types of cancers, both in clinical and preclinical cancer studies all around the …

The immunotherapeutic approaches based on checkpoint inhibitors, tumor vaccination,
immune cell-based therapy, and cytokines were developed to engage the patient's immune …